Krystal Biotech Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 10, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	6,663	4,352	3,166	1,909	1,532	967
Market Cap Growth	52.97%	37.47%	65.87%	24.59%	58.47%	13.17%
Enterprise Value	5,943	3,689	2,632	1,536	1,220	735
PE Ratio	39.30	50.54	320.10	-	-	-
PS Ratio	20.95	15.51	69.02	-	-	-
PB Ratio	6.87	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	6.87	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	47.21	37.81	-	-	-	-
P/OCF Ratio	44.37	36.51	-	-	-	-
EV/Sales Ratio	18.90	13.15	57.38	-	-	-
EV/EBITDA Ratio	43.75	36.14	-	-	-	-
EV/EBIT Ratio	44.53	37.01	-	-	-	-
EV/FCF Ratio	42.11	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.06	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.34	0.31	0.07	-	-	-
Inventory Turnover	0.76	1.20	-	-	-	-
Quick Ratio	9.43	6.89	17.35	13.14	17.02	17.56
Current Ratio	10.14	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	19.66%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	8.91%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Invested Capital (ROIC)	40.36%	31.60%	-40.54%	-76.89%	-74.23%	-177.13%
Return on Capital Employed (ROCE)	13.80%	10.80%	-12.40%	-22.90%	-11.60%	-11.20%
Earnings Yield	2.54%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.12%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-1.34%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.